Search Result "pentasa."
The Study of Marketed and Experimental Formulation Approaches Enabling Site-specific Delivery of Mesalamine in Patients with Inflammatory Bowel Disease
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 8 Issue: 1 Year: 2014 Page: 3-11
Author(s): Irina Kadiyala,Dylan Jacobs
Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?
Journal: Current Drug Targets
Volume: 12 Issue: 1 Year: 2011 Page: 1396-1405
Author(s): Mario Cottone, Sara Renna, Irene Modesto, Ambrogio Orlando
The Significant Role of Nutraceutical Compounds in Ulcerative ColitisTreatment
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 24 Year: 2022 Page: 4216-4234
Author(s): Azzurra Chiara De Maio,Maria Stefania Sinicropi
Randomized Controlled Trials in Active Luminal Crohnâs Disease
Journal: Reviews on Recent Clinical Trials
Volume: 7 Issue: 4 Year: 2012 Page: 290-296
Author(s): Fabiana Castiglione,Antonio Rispo
Biological Variability and Targeted Delivery of Therapeutics for Inflammatory Bowel Diseases: An In Silico Approach
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 6 Issue: 1 Year: 2007 Page: 47-55
Author(s): Nahor Haddish-Berhane, Ashkan Farhadi, Chell Nyquist, Kamyar Haghighi, Ali Keshavarzian
Effect of HPMC - E15 LV premium Polymer on Release Profile and Compression Characteristics of Chitosan/ Pectin Colon Targeted Mesalamine Matrix Tablets and in vitro Study on Effect of pH Impact on the Drug Release Profile
Journal: Recent Patents on Drug Delivery & Formulation
Volume: 8 Issue: 1 Year: 2014 Page: 46-62
Author(s): A.M.J. Newton,Prabakaran Lakshmanan
IBD Modern Concepts, Nano Drug Delivery and Patents: An Update
Journal: Recent Patents on Nanomedicine
Volume: 5 Issue: 2 Year: 2015 Page: 122-145
Author(s): Jatinder Kumar,Amaldoss Maria John Newton
Randomized Controlled Clinical Trials in Mild-Moderate Ulcerative Colitis
Journal: Reviews on Recent Clinical Trials
Volume: 7 Issue: 4 Year: 2012 Page: 256-269
Author(s): Maria Cappello,Claudia Randazzo,Ivana Bravata
Current Therapeutic Approaches in Inflammatory Bowel Disease
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 3668-3683
Author(s): Amir Ali Sohrabpour, Reza Malekzadeh, Ali Keshavarzian
Azo Reductase- Activated Colon- Targeting Prodrugs of Aminosalicylates for Inflammatory Bowel Disease: Preparation, Pharmacokinetic and Pharmacodynamic Profile
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 12 Issue: 6 Year: 2013 Page: 419-432
Author(s): Dhaneshwar Suneela,Vadnerkar Gaurav,Soares Samuel